康泰医学：拟使用不超过2.00亿元闲置自有资金进行现金管理

Core Viewpoint - The company plans to utilize idle self-owned funds for cash management, with a total amount not exceeding RMB 200 million, focusing on high-security and liquid financial products [1] Group 1: Company Actions - The company announced the convening of the 25th meeting of the fourth board of directors on February 26, 2026, to review the cash management proposal [1] - The approved cash management will allow the company to invest in financial products issued by legal and compliant financial institutions, including banks and securities companies [1] - The investment amount is valid for 12 months from the date of board approval and can be rolled over within the approved limit [1] Group 2: Financial Management Strategy - The cash management strategy aims to ensure that the use of idle funds does not affect the company's normal production operations and cash flow needs [1]